Swiss Parliament Votes In Favor of Adult Use Cannabis Legalization
3.1 min readPublished On: May 1st, 2021By News Team
ZÜRICH–Switzerland’s Health Commission of the Swiss House of Representatives, the Swiss National Council, in what will become an historic vote, has voted this past Friday, April 30th, in favor of legalizing cannabis for the Swiss. Adult-use of Cannabis in Switzerland is currently illegal, though minor possession was decriminalized to a fine in 2012.
The National Council’s public health committee voted 13 votes to 11 (with one abstention) to the parliamentary initiative by Representative, Mr. Heinz Siegenthaler (pictured). Essentially, the aim of the legislation is to regulate the cannabis market in Switzerland, rather than continue to ban Adult-Use.
This vote will make Switzerland the first country in Europe to allow a legal adult-use cannabis supply chain, according to reporting from Swiss news outlet, Zürichsee-Zeitung
The move means that Switzerland instantly joins the avant-garde of European cannabis. However, this is only the first important hurdle for full legalization of cannabis in Switzerland. The bill next goes to the Swiss Senate, which is called the Council of States.
With this move, the National Council’s public health commission has followed up on various other initiatives to legalize and regulate the cannabis market, rather than continue with the prohibition of adult-use cannabis. The proposed legislation has many features to protect Swiss consumers.
The Swiss Federal Office of Public Health noted they are conducting science-based consumer research trials on cannabis in order to offer “a scientific basis for the future regulation of cannabis.” These trials to check cannabis will be conducted in parallel to the legislation working its way through the representative chambers of the Swiss parliament.
The Swiss trial includes 5,000 registered participants, who already have been consuming cannabis illicitly. The trial program is a follow-up of an amendment to the Federal Act on Narcotics and Psychotropic Substances approved by the Swiss Government last September. The passed regulations enable a legal basis for conducting scientific pilot trials of cannabis.
The Swiss government’s research study requires that cannabis must be organic, produced in Switzerland and contain no more than 20% THC. The packaging requirements use the model of Canadian cannabis licenced producers, ensuring product containers are child-resistant, have safety warnings and the cannabinoid content of the products are clearly labeled, according to reporting in Neue Zürcher Zeitung.
Switzerland’s Federal Office of Public Health also released a statement that the current cannabis prohibitions are almost useless, as “despite this ban, consumption is high, the black market is thriving, and users’ safety is not guaranteed.”
According to some estimates, there are around 500,000 adult illicit cannabis consumers in Switzerland. Switzerland has already abolished criminal prosecution for possession of small amounts cannabis. Those caught with less than 10 grams only have to pay a CHF100 fine ($108.39). The sale of “light” cannabis with less than 1% THC is also legal in the country.
If passed, Switzerland not only becomes the first country in Europe to allow a legal adult-use cannabis supply chain, Switzerland might also beat the U.S.A. in legalization of cannabis at the federal level.
Recently, U.S. Senate Majority Leader Chuck Schumer (D-NY) said he plans to present a federal cannabis legalization bill soon. “I am going to put this bill on the floor soon. It hasn’t been introduced yet,” Schumer said, explaining he has been working with Senator Cory Booker (D-NJ) and Senate Finance Committee Chairman Ron Wyden (D-OR) on the measure’s draft. “Once it is introduced, it will go on the floor.”
Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
TORONTO - Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, announced today the launch of Peppermint Phatty 510 vape, the newest addition to the Good Supply vape ...
TALLAHASSEE, Fla. - Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), announced the official launch of Khalifa Kush premium medical marijuana products statewide in all Trulieve Branded Pennsylvania retail locations starting Monday, December 12, 2022. This ...
DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more